Efficacy and Safety of 177Lu-DOTA-IBA in Tumor Bone Metastasis Treatment
177Lu-DOTA-IBA is a promising bone-seeking radiopharmaceutical with a considerable pain relief rate and safety. It also can benefit some participants with bone metastases in imaging response.
Authors
- Naiguo Xing
- Tingting Xu
- Gengcuo Qu
- Guangfu Liu (ORCID: https://orcid.org/0000-0002-5840-9648)
- Hongmei Li (ORCID: https://orcid.org/0000-0001-9483-2964)
- Xiaoling Zhang (ORCID: https://orcid.org/0000-0001-5789-9676)
- Yudi Wang (ORCID: https://orcid.org/0000-0001-9289-0060)
- Qingchu Hua
- Yue Chen
- Wei J. Wang (ORCID: https://orcid.org/0000-0002-4848-7394)
Institutions
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- First Affiliated Hospital of Sichuan Medical University (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1097/rlu.0000000000005573
- Citations
- 10
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 4.04